Terms: = Sarcomas AND RANBP2, NUP358, 5903, ENSG00000153201, P49792, TRP1, TRP2
20 results:
1. Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets.
Vernemmen AIP; Samarska IV; Speel EM; Riedl RG; Goudkade D; de Bruïne AP; Wouda S; van Marion AM; Verlinden IV; van Lijnschoten I; Friederich P; Winnepenninckx VJL; Zur Hausen A; Sciot RME; van den Hout MFCM
Histopathology; 2024 Apr; 84(5):794-809. PubMed ID: 38155480
[TBL] [Abstract] [Full Text] [Related]
2. Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy.
Baranov E; Winsnes K; O'Brien M; Voss SD; Church AJ; Janeway KA; DuBois SG; Davis JL; Al-Ibraheemi A
Histopathology; 2022 Aug; 81(2):215-227. PubMed ID: 35543076
[TBL] [Abstract] [Full Text] [Related]
3. [Mesenchymal tumors and tumor-like lesions of the gastrointestinal tract: an overview].
Agaimy A
Pathologe; 2022 Feb; 43(1):31-44. PubMed ID: 34919183
[TBL] [Abstract] [Full Text] [Related]
4. Primary Cutaneous Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring ranbp2-ALK Fusion: Report of an Exceptional Case.
Gadeyne L; Creytens D; Dekeyser S; Van der Meulen J; Haspeslagh M
Am J Dermatopathol; 2022 Apr; 44(4):302-305. PubMed ID: 34816804
[TBL] [Abstract] [Full Text] [Related]
5. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
[TBL] [Abstract] [Full Text] [Related]
6. [Clinicopathological features of inflammatory myofibroblastic tumor].
Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
[No Abstract] [Full Text] [Related]
7. CD30 and ALK combination therapy has high therapeutic potency in ranbp2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma.
Fordham AM; Xie J; Gifford AJ; Wadham C; Morgan LT; Mould EVA; Fadia M; Zhai L; Massudi H; Ali ZS; Marshall GM; Lukeis RE; Fletcher JI; MacKenzie KL; Trahair TN
Br J Cancer; 2020 Sep; 123(7):1101-1113. PubMed ID: 32684628
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic utility of pan-Trk immunohistochemistry for inflammatory myofibroblastic tumours.
Yamamoto H; Nozaki Y; Kohashi K; Kinoshita I; Oda Y
Histopathology; 2020 Apr; 76(5):774-778. PubMed ID: 31578734
[TBL] [Abstract] [Full Text] [Related]
9. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract] [Full Text] [Related]
10. Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.
Fang H; Langstraat CL; Visscher DW; Folpe AL; Schoolmeester JK
Int J Gynecol Pathol; 2018 Sep; 37(5):468-472. PubMed ID: 28787324
[TBL] [Abstract] [Full Text] [Related]
11. Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma.
Jiang Q; Tong HX; Hou YY; Zhang Y; Li JL; Zhou YH; Xu J; Wang JY; Lu WQ
Orphanet J Rare Dis; 2017 May; 12(1):97. PubMed ID: 28535796
[TBL] [Abstract] [Full Text] [Related]
12. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
[TBL] [Abstract] [Full Text] [Related]
13. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
Yu L; Liu J; Lao IW; Luo Z; Wang J
Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
[TBL] [Abstract] [Full Text] [Related]
14. Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.
Liu Q; Kan Y; Zhao Y; He H; Kong L
Int J Clin Exp Pathol; 2015; 8(11):15328-32. PubMed ID: 26823889
[TBL] [Abstract] [Full Text] [Related]
15. Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis.
Lee JC; Wu JM; Liau JY; Huang HY; Lo CY; Jan IS; Hornick JL; Qian X
Cancer Cytopathol; 2015 Aug; 123(8):495-504. PubMed ID: 26139079
[TBL] [Abstract] [Full Text] [Related]
16. Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature.
Wu H; Meng YH; Lu P; Ning HY; Hong L; Kang XL; Duan MG
Int J Clin Exp Pathol; 2015; 8(4):4213-9. PubMed ID: 26097614
[TBL] [Abstract] [Full Text] [Related]
17. A case report of epithelioid inflammatory myofibroblastic sarcoma with ranbp2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
Kimbara S; Takeda K; Fukushima H; Inoue T; Okada H; Shibata Y; Katsushima U; Tsuya A; Tokunaga S; Daga H; Okuno T; Inoue T
Jpn J Clin Oncol; 2014 Sep; 44(9):868-71. PubMed ID: 25028698
[TBL] [Abstract] [Full Text] [Related]
18. Characterization of a family of ranbp2-type zinc fingers that can recognize single-stranded RNA.
Nguyen CD; Mansfield RE; Leung W; Vaz PM; Loughlin FE; Grant RP; Mackay JP
J Mol Biol; 2011 Mar; 407(2):273-83. PubMed ID: 21256132
[TBL] [Abstract] [Full Text] [Related]
19. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
[TBL] [Abstract] [Full Text] [Related]
20. Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice.
Tüting T; Gambotto A; DeLeo A; Lotze MT; Robbins PD; Storkus WJ
Cancer Gene Ther; 1999; 6(1):73-80. PubMed ID: 10078966
[TBL] [Abstract] [Full Text] [Related]